Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.460
+0.080 (3.36%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 6.00, which predicts an increase of 143.90% from the current stock price of 2.46.
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Lipocine stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $6 | Buy | Maintains | $6 | +143.90% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 6, 2026 |
Financial Forecast
Revenue This Year
776.40K
from 1.98M
Decreased by -60.72%
Revenue Next Year
1.09M
from 776.40K
Increased by 40.39%
EPS This Year
9.01
EPS Next Year
10.03
from 9.01
Increased by 11.32%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 776,400 | 1.1M | |
| Avg | 776,400 | 1.1M | |
| Low | 776,400 | 1.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -60.7% | 40.4% | |
| Avg | -60.7% | 40.4% | |
| Low | -60.7% | 40.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.01 | 10.03 | |
| Avg | 9.01 | 10.03 | |
| Low | 9.01 | 10.03 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 11.3% | - |
| Avg | 11.3% | - |
| Low | 11.3% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.